, Volume 38, Issue 3, pp 306–313 | Cite as

Prevalence of NIDDM and impaired glucose tolerance in Italy: an OGTT-based population study

  • M. P. Garancini
  • G. Calori
  • G. Ruotolo
  • E. Manara
  • A. Izzo
  • E. Ebbli
  • A. M. Bozzetti
  • L. Boari
  • P. Lazzari
  • G. Gallus


To provide complete prevalence data on diabetes mellitus in Italy (diagnosed and undiagnosed), a population survey was performed in the Health District of Cremona, a representative area of the Po river (north Italy). The survey is characterised by particular attention being paid to methodology, non-responders being investigated for possible selection biases affecting diagnosed and undiagnosed diabetes prevalence estimations. Out of a population aged 44 years or older from three municipalities, a random sample of 3097 subjects was selected to undergo an oral glucose tolerance test. In addition, past medical history, clinical and laboratory data were collected. A total of 1797 subjects participated (58%), and information on known diabetes status was obtained for 2618 persons (85%), also including 826 interviewed non-participating subjects. Overall rates were age-standardised according to the 1991 Italian census. Overall prevalence and 95% confidence interval of diagnosed diabetes was 8.5% (6.9–10.1) in males and 7.9% (6.7–9.3) in females over the age of 44 years; previously undiagnosed diabetes was 2.5% (1.4–3.6) in males and 3.4% (2.1–4.7) in females; glucose intolerance was 7.7% (5.7–9.7) in males and 8.9% (7.0–10.8) in females. Total diabetes prevalence above age 44 years, developed-world age, and sex standardised, was 10.7%. This study provides the first reliable prevalence estimation of impaired glucose tolerance, diagnosed and undiagnosed diabetes in Italy, according to World Health Organization criteria, and one of the few figures for Southern Europe. The role of body mass index on both prevalence of diabetes and cluster of cardiovascular risk factors is considered, with implications for prevention.

Key words

Population surveillance prevalence non-insulin-dependent diabetes mellitus glucose intolerance glucose tolerance test 



Oral glucose tolerance test


body mass index

C. I.

confidence intervals


  1. 1.
    Schranz AG (1989) Abnormal glucose tolerance in the Maltese. A population-based longitudinal study of the natural history of NIDDM and IGT in Malta. Diab Res Clin Pract 7: 7–16CrossRefGoogle Scholar
  2. 2.
    Garancini MP, Calori G, Manara E et al. (1993) An Italian population-based study of the prevalence of diabetes: some methodological aspects. Diabete Metab 19: 116–120PubMedGoogle Scholar
  3. 3.
    World Health Organization Expert Committee (1980) Second Report on diabetes mellitus. WHO Technical Report Series 646, GenevaGoogle Scholar
  4. 4.
    Annuario Statistico Italiano (1992). Sistema Statistico Nazionale. Istituto Nazionale di Statistica. Arti Grafiche Rubbettino, Battipaglia, pp. 56–62Google Scholar
  5. 5.
    Vu MT (1985) World Population Projection 1985. The Johns Hopkins University press, Baltimore, MD, pp 1–7Google Scholar
  6. 6.
    Gallus G, Garancini P (1991) Dati epidemiologici sul diabete mellito in Italia. Epidemiologia e prevenzione 48–49: 55–58CrossRefGoogle Scholar
  7. 7.
    Tuomilehto J, Nissinen A, Kivela SL et al. (1986) Prevalence of diabetes mellitus in elderly men aged 65 to 84 years in eastern and western Finland. Diabetologia 29: 611–615PubMedGoogle Scholar
  8. 8.
    Haavisto M, Mattila K, Rajala S (1983) Blood glucose and diabetes mellitus in subjects aged 85 years or more. Acta Med Scand 214: 239–244PubMedGoogle Scholar
  9. 9.
    Croxson SCM, Burden AC, Bodington M, Botha JL (1990) The prevalence of diabetes in elderly people. Diabet Med 8: 28–31Google Scholar
  10. 10.
    Andersson DKG, Svardsudd K, Tibblin G (1991) Prevalence and incidence of diabetes in a Swedish community 1972–1987. Diabet Med 8: 428–434PubMedGoogle Scholar
  11. 11.
    Tuomilehto J, Korhonen HJ, Kartovaara L et al. (1991) Prevalence of diabetes mellitus and impaired glucose tolerance in the middle-aged population of three areas in Finland. Int J Epidemiol 20: 1010–1017PubMedGoogle Scholar
  12. 12.
    Balkau B, Eschwege E, Fontbonne A, Claude JR, Warnet JM (1992) Cardiovascular and alcohol-related deaths in abnormal glucose tolerant and diabetic subjects. Diabetologia 35: 39–44PubMedGoogle Scholar
  13. 13.
    Zimmet P (1992) Kelly West Lecture 1991 — Challenges in diabetes epidemiology — From west to the rest. Diabetes Care 15: 232–252PubMedGoogle Scholar
  14. 14.
    Harris MI (1993) Undiagnosed NIDDM: clinical and public health issues. Diabetes Care 16: 642–652PubMedGoogle Scholar
  15. 15.
    French JR, Boen JR, Martinez AM, Bushhouse SA, Sprafka JM, Goetz FC (1990) Population-based study of impaired glucose tolerance and type II diabetes in Wadena, Minnesota. Diabetes 39: 1131–1137PubMedGoogle Scholar
  16. 16.
    Wingard DL, Sinsheimer P, Barrett-Connor EL, McPhillips JB (1990) Community-based study of prevalence of NIDDM in older adults. Diabetes Care 13: 3–8Google Scholar
  17. 17.
    Mikkanen L, Laakso M, Uusitupa M, Pyorala K (1990) Prevalence of diabetes and impaired glucose tolerance in elderly subjects and their association with obesity and family history of diabetes. Diabetes Care 13: 1099–1105PubMedGoogle Scholar
  18. 18.
    Tuomilehto J, Nissinen A, Kivela SL et al. (1986) Prevalence of diabetes mellitus in eldery men age 65 to 84 years in Eastern and Western Finland. Diabetologia 29: 611–615PubMedGoogle Scholar
  19. 19.
    Simmons D, Williams DRR, Powell MJ (1989) Prevalence of diabetes in a predominantly Asian community: preliminary findings of the Coventry diabetes study. BMJ 298: 18–21PubMedGoogle Scholar

Copyright information

© Springer-Verlag 1995

Authors and Affiliations

  • M. P. Garancini
    • 1
  • G. Calori
    • 1
  • G. Ruotolo
    • 2
  • E. Manara
    • 3
  • A. Izzo
    • 4
  • E. Ebbli
    • 4
  • A. M. Bozzetti
    • 5
  • L. Boari
    • 3
  • P. Lazzari
    • 3
  • G. Gallus
    • 1
  1. 1.Medical Statistics and Epidemiology Unit, Medical SchoolUniversity of Milan, S. Raffaele Scientific InstituteMilanItaly
  2. 2.Lipid Metabolism LaboratoryS. Raffaele Scientific InstituteMilanItaly
  3. 3.Hospital of CremonaCremonaItaly
  4. 4.Staff District OfficeCremonaItaly
  5. 5.Casalbuttano Health DistrictCasalbuttanoItaly

Personalised recommendations